Our Offices
US
16192 Coastal Highway, Lewes, United States of America.
SG
Vision Exchange, # 13-30, No-02 Venture Drive, Singapore-608526
KSA
3738 King Abdullah Branch Rd, 6258 Al Muhammadiyah Dist, 12362, Riyadh, Saudi Arabia
UAE
3401, 34th Floor, Saeed Tower 2, Sheikh Zayed Road, PO Box No. 114429. Dubai, UAE
UK
Level 1, Devonshire House, 1 Mayfair Place, Mayfair W1J 8AJ United Kingdom
IN
2nd Floor, Omaxe Square, Jasola, Behind Apollo Hospital, New Delhi, Delhi 110025
BD
Level-6, House 77, Road-12, Block-E, Banani, Dhaka-1213
TR
Regus - Atasehir Palladium Office Barbaros, Palladium Office and Residence Building, Halk Cd. No:8/A Floor 2 & 3, 34746 Ataşehir/İstanbul
TH
Axcel Health Co. Ltd., UnionSpace Building, 30 Soi Sukhumvit 61, Khlongton-nua, Wattana, Bangkok 10110. Thailand.
NG
Dr Hassan’s Hospital, 5 Katsina Ala street, Maitama- Abuja Nigeria
ET
Heulet 22, Golagol tower, Addis Ababa, Ethiopia
EG
Building 145, Sahl Hamza, Alfaisal Street, Giza - Cairo Egypt
ZA
Building 9, Fountain View House, Vlakhaas Ave, Constantia Kloof, Roodepoort, 1709
2024, Healthtrip.com All rights reserved.
26 Oct, 2023
Lung cancer is a type of cancer that begins in the lungs, which are essential organs for breathing located in the chest. The lungs are responsible for taking in oxygen from the air we breathe and expelling carbon dioxide, a waste product of the body's processes.
Find the right cosmetic procedure for your needs.
We specialize in a wide range of cosmetic procedures
Lung cancer occurs when cells in the lungs undergo abnormal changes, leading to uncontrolled growth and the formation of tumors. These tumors can interfere with the normal functioning of the lungs, affecting breathing and, if left untreated, can spread to other parts of the body through the bloodstream or lymphatic system.
According to the World Health Organization (WHO) Lung cancer is the leading cause of cancer death worldwide, accounting for an estimated millions of deaths each year.
It is the second most common cancer worldwide, after skin cancer.
Lung cancer is more common in men than in women, but the incidence rate in women has been increasing in recent years.
The five-year survival rate for lung cancer is 20% worldwide,
Non-Small Cell Lung Cancer (NSCLC) constitutes the majority of lung cancer cases, accounting for approximately 85% of diagnoses. It is a diverse group that includes various subtypes:
Total Hip Replacemen
Upto 80% off
90% Rated
Satisfactory
Total Hip Replacemen
Upto 80% off
90% Rated
Satisfactory
Breast Cancer Surger
Upto 80% off
90% Rated
Satisfactory
Total Knee Replaceme
Upto 80% off
90% Rated
Satisfactory
Total Knee Replaceme
Upto 80% off
90% Rated
Satisfactory
Small Cell Lung Cancer (SCLC) is a more aggressive type, representing about 15% of lung cancer cases. It is strongly associated with smoking.
Beyond NSCLC and SCLC, there are rarer subtypes, including:
The staging of lung cancer is crucial for determining the extent of the disease and guiding treatment decisions. It helps oncologists design an appropriate and personalized treatment plan, considering factors such as the size and location of the tumor, lymph node involvement, and the presence of distant metastasis. Staging also plays a significant role in predicting prognosis and outcomes for individuals with lung cancer.
Surgery is a primary treatment for lung cancer, particularly in the early stages. Different surgical approaches may be employed, ranging from removing a portion of the lung (wedge resection) to the removal of an entire lobe (lobectomy) or even the whole lung (pneumonectomy). The goal is to eliminate the cancerous tissue and, if possible, any nearby lymph nodes where the cancer may have spread. Surgical interventions are most effective when the cancer is localized and has not extensively invaded surrounding tissues.
Radiation therapy employs high doses of radiation to target and destroy cancer cells. This treatment is often used either before surgery to shrink tumors or after surgery to eliminate any remaining cancer cells. It can also be a primary treatment for those who are not surgical candidates. External beam radiation, where the radiation source is directed from outside the body, and brachytherapy, involving internal radiation with implanted devices, are common approaches. Radiation therapy is valuable in cases where localized treatment is necessary.
Chemotherapy utilizes powerful drugs to kill rapidly dividing cancer cells throughout the body. This systemic treatment is often employed when cancer has spread beyond the lungs or in cases where surgery or radiation alone may not be sufficient. Chemotherapy can be administered intravenously or orally, and the choice of drugs depends on the type and stage of lung cancer. While effective in targeting cancer cells, chemotherapy can also affect normal, healthy cells, leading to side effects.
Targeted therapy focuses on specific molecules involved in cancer growth and progression. This treatment is tailored to the molecular characteristics of the cancer, and drugs are designed to inhibit or block specific pathways that cancer cells use to grow. Common targets include epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK). Targeted therapy is often well-tolerated and can be particularly effective in cases with specific genetic mutations.
Immunotherapy harnesses the body's immune system to recognize and destroy cancer cells. Checkpoint inhibitors, a common form of immunotherapy, block proteins that prevent immune cells from attacking cancer cells. Another approach involves genetically modifying T cells (CAR T-cell therapy) to enhance their cancer-fighting capabilities. Immunotherapy has shown promising results, especially in advanced stages of lung cancer, and is contributing to a shift in the treatment landscape towards more personalized and targeted approaches.
Smoking is the leading risk factor for lung cancer, accounting for about 80% of all cases.
Lung cancer, a formidable adversary in the realm of health, often arises from a complex interplay of risk factors that extend beyond individual choices. While the primary culprit is unquestionably cigarette smoking, the multifaceted nature of these risk factors underscores the need for a nuanced approach to prevention.
Unquestionably the most significant risk factor, a history of cigarette smoking remains the leading cause of lung cancer. Both current and former smokers are at elevated risk, and the duration and intensity of smoking amplify this risk. The chemical cocktail within tobacco smoke inflicts profound and lasting damage to the delicate cells of the lungs, setting the stage for malignancy.
Beyond personal habits, environmental factors contribute significantly. Secondhand smoke, often underestimated, poses a substantial risk, particularly in enclosed spaces and workplaces. Occupational hazards, such as prolonged exposure to asbestos, radon, and certain chemicals, elevate the risk profile. Initiatives to reduce exposure in workplaces and public spaces are crucial in curbing these environmental threats.
A familial predisposition to lung cancer, while less common, can elevate individual risk. Genetic factors may influence susceptibility, making it imperative for individuals with a family history of lung cancer to be vigilant and proactive in adopting preventive measures. Genetic counseling and testing can shed light on potential predispositions, allowing for tailored risk management.
Advancing age remains a non-negotiable risk factor, with the majority of lung cancer cases diagnosed in individuals over 65. Moreover, gender plays a role, with historically higher rates in men. However, the gap is narrowing, possibly due to shifts in smoking patterns over the years.
Lung cancer, with its intricate web of complexities, doesn't merely confine its impact to the lungs; it often unfurls a cascade of complications that reverberate throughout the body. Understanding these complications is essential not only for comprehensive patient care but also for tailoring treatment strategies that address the multifaceted nature of the disease.
Perhaps the most ominous complication, metastasis marks the point where lung cancer extends its reach beyond its initial location. Cancer cells break away, traveling through the bloodstream or lymphatic system to distant organs like the liver, bones, or brain. Metastasis significantly alters treatment approaches, demanding a more comprehensive and targeted strategy to address cancer's widespread influence.
Given the lungs' central role in the respiratory system, it's unsurprising that lung cancer can precipitate a range of breathing-related complications. As tumors grow, they may obstruct air passages, leading to shortness of breath and persistent coughing. Additionally, the compromised lung function may result in pneumonia or other respiratory infections, further taxing an already weakened system.
Lung cancer doesn't merely confine its impact to the primary tumor site; it can instigate paraneoplastic syndromes, where cancer cells release substances that affect distant tissues and organs. These syndromes can manifest in a variety of ways, from hormonal imbalances to neurological complications, adding layers of complexity to the overall clinical picture.
Preventing lung cancer involves a strategic and concerted effort to mitigate risk factors and foster a culture of respiratory well-being. Here's a comprehensive guide on how to safeguard against this formidable disease:
The unequivocal leading cause of lung cancer is smoking. Engage in smoking cessation programs, which offer a combination of counseling, support groups, and nicotine replacement therapies. Quitting smoking significantly reduces the risk of developing lung cancer and contributes to overall health.
Recognize the risks of secondhand smoke. Create smoke-free environments at home and advocate for smoke-free policies in public spaces. Protecting non-smokers from the harmful effects of passive smoking is integral to preventing lung cancer.
For those working in industries associated with lung cancer risks (e.g., construction, mining), strict adherence to occupational safety guidelines is paramount. Proper use of protective equipment and minimizing exposure to carcinogens can substantially reduce the risk.
Radon, a naturally occurring radioactive gas, is a significant risk factor. Test homes and workplaces for radon levels, and if elevated, implement mitigation strategies. Proper ventilation and sealing entry points can effectively reduce radon exposure.
Adopting a healthy lifestyle contributes to overall well-being and can indirectly reduce lung cancer risk. Maintain a balanced diet rich in fruits and vegetables, engage in regular physical activity, and stay hydrated. A robust immune system is better equipped to thwart cancerous developments.
Regular medical check-ups and screenings are instrumental in early detection. High-risk individuals, such as current or former smokers, should discuss the possibility of lung cancer screenings with their healthcare providers. Early detection allows for more effective treatment.
lung cancer's complexity requires a nuanced approach. Early detection through recognizing symptoms and regular screenings is crucial. Smoking cessation, awareness, and timely interventions are key preventive measures. With diverse treatment options and advancing research, there's hope in improving outcomes. By prioritizing prevention and awareness, we can make significant strides in the fight against lung cancer.
If you're on the lookout for treatment in India, Thailand, Singapore, Malaysia, UAE, and Turkey, let Healthtrip be your compass. We will serve as your guide throughout your medical treatment. We'll be by your side, in person, even before your medical journey commences. The following will be provided to you:
Wellness Treatments
Give yourself the time to relax
Lowest Prices Guaranteed!
Lowest Prices Guaranteed!
67K+
Patients
Served
38+
Countries
Reached
1538+
Hospitals
Partners